Paper42017290
Bifidobacterium bifidum G9-1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open-Label, Randomized Controlled Trial (Binary STAR Study).
Kobayashi G and 10 others. Diabetes Obes Metab, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Bifidobacterium bifidum G9-1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open-Label, Randomized Controlled Trial (Binary STAR Study). Papers, record 42017290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42017290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bifidobacterium bifidum G9-1 Intake Improves Gastrointestinal Symptoms in Type 2 Diabetes Mellitus: An Open-Label, Randomized Controlled Trial (Binary STAR Study).
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Bifidobacterium bifidum | Major topic |
| Constipation | Major topic |
| Probiotics | Major topic |
| Diarrhea | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Aged | |
| Male | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| the Biofermin Pharmaceutical Co. Ltd. | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31544979 | Probiotic Bifidobacterium bifidum G9-1 ameliorates phytohemagglutinin-induced diarrhea caused by intestinal dysbiosis. | Microbiol Immunol | 2019 | https://conductscience.org/library/papers/31544979 | PubMed |
| 2 | 41412135 | 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. | Lancet Diabetes Endocrinol | 2026 | https://conductscience.org/library/papers/41412135 | PubMed |
| 3 | 37299544 | Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/db Mice. | Nutrients | 2023 | https://conductscience.org/library/papers/37299544 | PubMed |
| 4 | 30683 | Short chain fatty acid absorption by the human large intestine. | Gut | 1978 | https://conductscience.org/library/papers/30683 | PubMed |
| 5 | 17659688 | Placebo responses in patients with gastrointestinal disorders. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17659688 | PubMed |
| 6 | 23023125 | A metagenome-wide association study of gut microbiota in type 2 diabetes. | Nature | 2012 | https://conductscience.org/library/papers/23023125 | PubMed |
| 7 | 31467327 | Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans. | Sci Rep | 2019 | https://conductscience.org/library/papers/31467327 | PubMed |
| 8 | 27431262 | A Practical Approach to Gastrointestinal Complications of Diabetes. | Diabetes Ther | 2016 | https://conductscience.org/library/papers/27431262 | PubMed |
| 9 | 24553467 | Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. | ISME J | 2014 | https://conductscience.org/library/papers/24553467 | PubMed |
| 10 | 32802702 | Japanese Clinical Practice Guideline for Diabetes 2019. | Diabetol Int | 2020 | https://conductscience.org/library/papers/32802702 | PubMed |
| 11 | 11558866 | A systematic review of the associations between dose regimens and medication compliance. | Clin Ther | 2001 | https://conductscience.org/library/papers/11558866 | PubMed |
| 12 | 40604123 | Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes. | NPJ Metab Health Dis | 2025 | https://conductscience.org/library/papers/40604123 | PubMed |
| 13 | 24336217 | Diet rapidly and reproducibly alters the human gut microbiome. | Nature | 2014 | https://conductscience.org/library/papers/24336217 | PubMed |
| 14 | 18801055 | Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. | Aliment Pharmacol Ther | 2009 | https://conductscience.org/library/papers/18801055 | PubMed |
| 15 | 34665938 | Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial. | J Diabetes Investig | 2022 | https://conductscience.org/library/papers/34665938 | PubMed |
| 16 | 11525701 | Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. | Arch Intern Med | 2001 | https://conductscience.org/library/papers/11525701 | PubMed |
| 17 | 18812643 | Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. | J Physiol Pharmacol | 2008 | https://conductscience.org/library/papers/18812643 | PubMed |
| 18 | 33765447 | The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. | Lancet Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/33765447 | PubMed |
| 19 | 39283347 | Genetic optimization of the human gut bacterium Phocaeicola vulgatus for enhanced succinate production. | Appl Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/39283347 | PubMed |
| 20 | 24815298 | Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. | Aliment Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24815298 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42017290
GET https://conductscience.org/api/papers/v1/42017290/references?page=2